LEFT-VENTRICULAR HYPERTROPHY AS A RISK FACTOR for ARRHYTHMIAS in HEMODIALYSIS-PATIENTS

Página do item simplificado
dc.contributor.authorSaragoca, Manoel A. [UNIFESP]
dc.contributor.authorCanziani, M. E. [UNIFESP]
dc.contributor.authorCassiolato, José L.
dc.contributor.authorGil, M. A. [UNIFESP]
dc.contributor.authorAndrade, J. L. [UNIFESP]
dc.contributor.authorDraibe, S. A. [UNIFESP]
dc.contributor.authorMartinez, E. E. [UNIFESP]
dc.contributor.institutionUniversidade Federal de São Paulo (UNIFESP)
dc.contributor.institutionCENTROCOR
dc.date.accessioned2016-01-24T11:40:00Z
dc.date.available2016-01-24T11:40:00Z
dc.date.issued1991-01-01
dc.description.abstractThe contribution of left ventricular hypertrophy in determining ventricular arrhythmias (VAS) was studied in 81 chronic renal failure patients in chronic hemodialysis using two-dimensional echocardiographic and electrocardiogram Holter monitoring. the prevalence of LVH was 93% (96% in hypertensive and 87% in normotensive patients). the prevalence of VA was 48%. These arrhythmias were associated with increased cardiac mass, lack of potassium supplementation to the hemodialysis bath, and low K+ and PaO2 during dialysis. Severe forms of VA occurred in 19 of 78 patients, and the risk factors for this occurrence were (a) largely increased cardiac mass indices (exceeding in more than 40% the upper limit of normal for each sex) and (b) prolonged periods of time in hemodialysis treatment (34 +/- 5.5 vs. 17 +/- 2.7 months, p < 0.05). Changes in potassium or oxygen content of the blood were not significantly associated with the occurrence of severe forms of VA.en
dc.description.affiliationESCOLA PAULISTA MED SCH,DIV CARDIOL,BR-04023 São Paulo,BRAZIL
dc.description.affiliationCENTROCOR,São Paulo,BRAZIL
dc.description.affiliationUnifespESCOLA PAULISTA MED SCH,DIV CARDIOL,BR-04023 São Paulo,BRAZIL
dc.description.sourceWeb of Science
dc.format.extentS136-S138
dc.identifierhttp://dx.doi.org/10.1097/00005344-199117002-00032
dc.identifier.citationJournal of Cardiovascular Pharmacology. Philadelphia: Lippincott-raven Publ, v. 17, p. S136-S138, 1991.
dc.identifier.doi10.1097/00005344-199117002-00032
dc.identifier.issn0160-2446
dc.identifier.urihttp://repositorio.unifesp.br/handle/11600/25174
dc.identifier.wosWOS:A1991FU76000032
dc.language.isoeng
dc.publisherLippincott-raven Publ
dc.relation.ispartofJournal of Cardiovascular Pharmacology
dc.rightsinfo:eu-repo/semantics/openAccess
dc.subjectLEFT VENTRICULAR HYPERTROPHYen
dc.subjectCARDIAC HYPERTROPHYen
dc.subjectVENTRICULAR ARRHYTHMIASen
dc.subjectCHRONIC RENAL FAILUREen
dc.subjectHEMODIALYSISen
dc.titleLEFT-VENTRICULAR HYPERTROPHY AS A RISK FACTOR for ARRHYTHMIAS in HEMODIALYSIS-PATIENTSen
dc.typeinfo:eu-repo/semantics/article
Arquivos
Coleções
EPM - Artigos